Kayexalate - Nephronor - Chirurgie
|
PrKAYEXALATE
KAYEXALATE is a cation-exchange resin prepared in the sodium phase with an in vivo exchange capacity of approximately 1 mmol (in vitro approximately 3 1 mmol) of potassium per gram The sodium content is approximately 4 1 mmol (100 mg) per gram of the drug KAYEXALATE can be administered either orally or as an enema ACTION |
Is Kayexalate a cation exchange polymer?
KAYEXALATE is a non-absorbed, cation exchange polymer that contains a sodium counterion. KAYEXALATE increases fecal potassium excretion through binding of potassium in the lumen of the gastrointestinal tract.
How effective is Kayexalate?
Kayexalate is not effective as acute therapy, but a new randomized controlled trial suggests that it is effective when given more chronically. Gastrointestinal side effects and safety concerns about Kayexalate remain. New investigational potassium binders are likely to be approved in the coming year.
How much sodium is in Kayexalate?
The sodium content is approximately 100 mg (4.1 mEq) per gram of the drug. It can be administered orally or rectally as an enema. One gram of KAYEXALATE contains 4.1 mEq of sodium. 12.1 Mechanism of Action KAYEXALATE is a non-absorbed, cation exchange polymer that contains a sodium counterion.
Who should be consulted before taking Kayexalate oral?
A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment. Find patient medical information for Kayexalate oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
Overview
Package insert / product label Generic name: sodium polystyrene sulfonate Dosage form: powder, for suspension Drug class: Cation exchange resins drugs.com
Highlights of Prescribing Information
These highlights do not include all the information needed to use KAYEXALATE safely and effectively. See full prescribing information for KAYEXALATE KAYEXALATE (sodium polystyrene sulfonate) powder for suspension, for oral or rectal use drugs.com
Indications and Usage for Kayexalate
KAYEXALATE is a potassium binder indicated for the treatment of hyperkalemia (1) Limitation of Use: drugs.com
Kayexalate Dosage and Administration
Oral: The average total daily adult dose of KAYEXALATE is 15 g to 60 g, administered as a 15-g dose (four level teaspoons), one to four times daily (2.1). Rectal: The average adult dose is 30 g to 50 g every six hours (2.1). drugs.com
Dosage Forms and Strengths
KAYEXALATE is available as a cream to light brown, finely ground powder (3) drugs.com
Contraindications
•Hypersensitivity to polystyrene sulfonate resins (4) •Obstructive bowel disease (4) drugs.com
Warnings and Precautions
•Intestinal Necrosis: cases of intestinal necrosis and other serious gastrointestinal events have been reported (5.1). •Electrolyte Disturbances: Severe hypokalemia can occur. (5.2). •Fluid overload in patient sensitive to high sodium intake: Monitor patients who are sensitive to sodium intake for signs of fluid overload. (5.3). •Risk of aspiration: Acute bronchitis or bronchopneumonia caused by inhalation of sodium polystyrene sulfonate particles has been reported. (5.4). drugs.com
Adverse Reactions/Side Effects
Adverse reactions reported include: anorexia, constipation, diarrhea, fecal impaction, gastrointestinal concretions (bezoars), ischemic colitis, nausea, vomiting (6). To report SUSPECTED ADVERSE REACTIONS, contact Concordia Pharmaceutical Inc. at 1-877-370-1142 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. drugs.com
Drug Interactions
•Take other orally administered drugs at least 3 hours before or 3 hours after KAYEXALATE (7.1). •Cation-Donating Antacids: may reduce the resin’s potassium exchange capability and increase risk of systemic alkalosis (7.2). •Sorbitol: Concomitant use may contribute to the risk of intestinal necrosis and is not recommended (7.3). See 17 for PATIENT COUNSELING INFORMATION. drugs.com
Related/similar drugs
sodium bicarbonate, insulin regular, Lokelma, calcium gluconate, Humulin R, Veltassa drugs.com
Kayexalate
Medical Mythbusters – Kayexalate is Safe and Effective for Treating Acute Hyperkalemia
Nephron Sparing Surgery for Large Renal Tumors
|
LACIDOSE TUBULAIRE RÉNALE
Chirurgie Cardio-Vasculaire Pr TAOBANE Hamid* Chirurgie Générale- Directeur CHIS Kayexalate per os ou en lavement dans les acidoses avec |
|
La place du pharmacien dofficine dans léducation thérapeutique du
La chirurgie vasculaire rénale permettant la revascularisation est exceptionnelle de nos Le KAYEXALATE® est le traitement médicamenteux de référence de |
